Zepp Health Corporation Stock Price, News & Analysis

Amazfit, owned by Zepp Health (NYSE: ZEPP), has announced a multi-year partnership with Italian tennis star Jasmine Paolini, currently World No. 4 and the highest-ranked Italian singles player in WTA history. As part of the agreement, Paolini will wear Amazfit logo and smartwatch during matches and use the brand's fitness wearables, including Helio Ring, for tracking sleep and athletic recovery.

Paolini's achievements include reaching finals at the 2024 French Open (singles and doubles) and 2024 Wimbledon (singles), winning an Olympic gold medal in doubles, and securing two WTA singles and six doubles titles. The partnership aims to leverage Amazfit's advanced tracking technology to monitor key performance metrics like heart health, sleep quality, and exertion load.

Paolini joins Amazfit's roster of elite athletes, including Yeman Crippa, Gabby Thomas, and others. The company's product ecosystem includes Active, Cheetah and T-Rex series smartwatches, Helio smart ring, and the Zepp App with its new Food Log feature.

Amazfit, owned by Zepp Health (NYSE: ZEPP), has announced a four-year partnership with five-time Olympic Medalist Gabby Thomas as their latest athlete ambassador. Thomas, who emerged as the most decorated U.S. track and field athlete at the 2024 Paris Olympics with gold medals in 200m, 4x100m, and 4x400m events, will utilize Amazfit smartwatches during training and competition.

This marks Thomas' first smartwatch partnership, highlighting the importance of data in athletic performance. She will use Amazfit's devices to track heart rate, recovery, sleep quality, and nutrition through the Zepp app's food log feature. Thomas will also provide feedback to Amazfit's development teams on future product features and styles.

The partnership aligns with Amazfit's commitment to holistic health and well-being across physical fitness, sleep, mindfulness, and nutrition. Thomas joins other notable Amazfit athletes, including HYROX World Champions and Olympians.

Zepp Health (NYSE: ZEPP) has announced its participation in CES Pepcom and ShowStoppers media events to showcase its latest smart wearables and health technology innovations. The company will present several new products including:

The Amazfit Active 2 Smartwatch Series featuring Zepp Coach™, Zepp Flow™ voice assistant, and 160+ sports modes; the Amazfit V1TAL Prototype, a device with advanced nutritional tracking and high-definition video capture capabilities; and the Zepp Clarity Pixie hearing aids.

Additional innovations include a revamped Zepp App with enhanced features like Zepp Coach™, Zepp Aura, and Food Log, plus new health solutions for women powered by Wild.AI integration. The showcases will take place at Caesars Palace (January 6th) and Bellagio (January 7th).

Zepp Health (NYSE: ZEPP) has announced the launch of its new Amazfit Active 2 smartwatch at CES 2025. The device features a 1.32-inch AMOLED display with 2,000 nits brightness and comes in two versions: a premium model at $129.99 with leather strap and sapphire glass, and a standard version at $99.99 with silicone strap.

The watch incorporates advanced technology including the BioTracker™ 6.0 PPG biosensor, upgraded heart rate and sleep monitoring algorithms, and new sensors for altitude and movement tracking. It offers a 10-day battery life and includes features like Zepp Flow™ for voice control and Zepp Pay for contactless payments in Europe.

The device supports over 160 sports modes, offline maps with turn-by-turn navigation, and includes Zepp Coach™ for personalized training. Pre-orders are available in the US, with global release scheduled for February 2025.

Zepp Health (NYSE: ZEPP) has launched a 'Try Before You Buy' program for OTC hearing aids at CES 2025, addressing low adoption rates among adults with hearing loss. The initiative allows customers to test three models—Clarity Omni, Clarity One, and Clarity Pixie—in their homes before purchase.

The company introduced the Zepp Clarity Pixie, a next-generation hearing aid priced at $1,499, featuring a nearly invisible design, titanium alloy shell, IPX7 water resistance, and 17-hour battery life. The device includes Clarity Boost, Smart Phone Call support, and Find Device functionality, manageable through the Zepp Clarity App with eight customizable programs.

The program aims to tackle the low adoption rate of hearing aids, as only 15-30% of adults with mild-to-moderate hearing loss currently use them. All Zepp Clarity devices are FDA-Exempt Class II medical devices, targeting adults 18 and older, and come with lifetime customer support and certified audiologist access.

Zepp Health reported Q3 2024 financial results with revenues of US$42.5 million, representing a 48.9% decrease year-over-year. The company achieved a 40.6% gross margin, its highest quarterly margin, despite reporting a net loss of US$13.3 million. Amazfit branded sales showed a 10% quarter-over-quarter increase, marking the highest sequential growth in 2024. The company's T-Rex3 smartwatch launch received positive market feedback, while total units shipped decreased to 0.7 million from 2.8 million in Q3 2023. For Q4 2024, Zepp expects revenues between US$55-70 million, representing 29-65% growth for self-branded products compared to Q3.

Zepp Health (NYSE: ZEPP) has scheduled its third quarter 2024 financial results announcement for November 18, 2024, after market close. The company will host a conference call at 8:30 p.m. Eastern Time on the same day. The earnings call will be accessible via phone and webcast, with dial-in numbers provided for US, International, Mainland China, and Hong Kong participants. A replay of the conference call will be available until November 25, 2024.

Zepp Health has launched the enhanced Zepp App 9, designed to provide a more personalized health and wellness experience for Amazfit users. The update features a streamlined interface with color-coded statistics, enhanced smart analytics, and real-time data analysis. Key additions include a daily personalized exertion score, heart health dashboard, and Zepp Aura Premium Service for advanced sleep insights. The app offers mini-apps, watch faces, and third-party integrations with platforms like Strava and adidas Running. Data protection is ensured through AWS storage and GDPR compliance.

Zepp Health (NYSE: ZEPP), a global leader in smart wearables and health technology, has regained compliance with the New York Stock Exchange's (NYSE) continued listing criterion of a minimum share price. The company received a letter from the NYSE on October 2, 2024, confirming its compliance with Section 802.01C of the NYSE Listed Company Manual.

This development follows a previous notification from the NYSE on April 30, 2024, which informed Zepp Health that it had fallen below compliance standards due to its American depositary shares' average closing price being less than $1.00 for a consecutive 30 trading-day period. With this new confirmation, Zepp Health is no longer considered below the NYSE Minimum Price Continued Listing Criterion.